PENN PHARMACEUTICAL SERVICES LIMITED

Company number 01331447

Date	Type	Description	View / Download
15 Oct 2020	CH01	Director's details changed for Mr Serge Dupuis on 25 September 2020	(2 pages)
02 Jun 2020	CH01	Director's details changed for Mr Sujit John on 31 May 2020	(2 pages)
03 Mar 2020	AA	Full accounts made up to 30 June 2019	(29 pages)
10 Oct 2019	AP01	Appointment of Mr Serge Dupuis as a director on 26 June 2019	(2 pages)
10 Oct 2019	TM01	Termination of appointment of William T Mitchell, Iii as a director on 26 June 2019	(1 page)
01 Oct 2019	CS01	Confirmation statement made on 26 September 2019 with updates	(4 pages)
06 Aug 2019	RP04CS01	Second filing of Confirmation Statement dated 26/09/2018	(5 pages)
06 Aug 2019	RP04CS01	Second filing of Confirmation Statement dated 26/09/2016	(5 pages)
06 Aug 2019	RP04AR01	Second filing of the annual return made up to 26 September 2015	(23 pages)
06 Aug 2019	RP04AR01	Second filing of the annual return made up to 26 September 2014	(23 pages)
06 Aug 2019	RP04SH01	Second filing of a statement of capital following an allotment of shares on 18 December 2013 GBP 430,695	(7 pages)
12 Jul 2019	RP04CS01	Second filing of Confirmation Statement dated 26/09/2017	(5 pages)
04 Apr 2019	AA	Full accounts made up to 30 June 2018	(28 pages)
03 Oct 2018	CS01	26/09/18 Statement of Capital gbp 430695 ANNOTATION Clarification a second filed CS01 statement of capital was registered on 06/08/2019	(5 pages)
03 Oct 2018	CH01	Director's details changed for Mr William T Mitchell, Iii on 1 September 2018	(2 pages)
02 Oct 2018	AP01	Appointment of Mr Salim Haffar as a director on 20 September 2018	(2 pages)
29 Jun 2018	TM01	Termination of appointment of Mitchell Eric Blumenfeld as a director on 1 June 2018	(1 page)
05 Apr 2018	AA	Full accounts made up to 30 June 2017	(27 pages)
06 Oct 2017	CS01	Confirmation statement made on 26 September 2017 with updates ANNOTATION Clarification a second filed CS01 (Shareholder information change) was registered on 12/07/2019.	(6 pages)
06 Oct 2017	PSC02	Notification of Penn Pharma Group Limited as a person with significant control on 17 March 2017	(1 page)
06 Oct 2017	PSC09	Withdrawal of a person with significant control statement on 6 October 2017	(2 pages)
26 Sep 2017	CH01	Director's details changed for Mr John Sujit on 1 September 2017	(2 pages)
06 Apr 2017	AA	Full accounts made up to 30 June 2016	(29 pages)
08 Nov 2016	TM01	Termination of appointment of Joseph Edward Whitters as a director on 1 July 2016	(1 page)
08 Nov 2016	TM01	Termination of appointment of Tachi Yamada as a director on 1 July 2016	(1 page)